Chardan Capital Issues Positive Forecast for Hyperliquid Strategies (NASDAQ:PURR) Stock Price

Hyperliquid Strategies (NASDAQ:PURR) had its target price hoisted by Chardan Capital from $8.15 to $8.45 in a report issued on Thursday,Benzinga reports. Chardan Capital currently has a buy rating on the stock.

Hyperliquid Strategies Stock Performance

PURR opened at $4.26 on Thursday. Hyperliquid Strategies has a 52-week low of $3.01 and a 52-week high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last issued its earnings results on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. HRT Financial LP acquired a new stake in shares of Hyperliquid Strategies during the fourth quarter worth approximately $856,000. Jane Street Group LLC bought a new stake in shares of Hyperliquid Strategies during the 4th quarter valued at about $339,000. Finally, EHP Funds Inc. bought a new position in Hyperliquid Strategies in the fourth quarter worth about $302,000. Hedge funds and other institutional investors own 9.45% of the company’s stock.

Key Hyperliquid Strategies News

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Cantor Fitzgerald raised its price target to $6.00 and moved to an “overweight” rating, implying roughly ~41% upside from the referenced price; this is a near-term bullish analyst signal. Cantor Fitzgerald upgrade
• Positive Sentiment: Chardan Capital raised its target to $8.45 and reiterated a “buy” rating, signaling a materially higher upside (~98% vs. the referenced level) that could attract buyers if confidence in execution improves. Chardan Capital upgrade
• Neutral Sentiment: Short-interest reports show “0” shares and a 0.0 days-to-cover figure for early February — likely a reporting anomaly or timing issue rather than meaningful short activity; this creates ambiguity rather than a clear market pressure.
• Neutral Sentiment: The company issued a press release with its financial results and management commentary noting it is “encouraged by our early execution” after going public; tone is constructive but must be weighed against the reported loss. PR Newswire release
• Negative Sentiment: Hyperliquid reported quarterly EPS of ($7.43), a sizeable loss that is the most direct negative driver for the stock and likely the primary reason for downward pressure on the share price today. Earnings report

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.